Accurate donor and recipient selection and a short time to transplant offer excellent outcomes in upfront hematopoietic stem cell transplantation from matched unrelated donors for pediatric severe aplastic anemia and refractory cytopenia of childhood. A study of the Spanish Pediatric Group for Hematopoietic Cell Transplantation and Cell Therapy (GETH-TC)


Por: Uria-Oficialdegui ML, Quintero V, Benitez-Carabante MI, Bueno D, Trabazo-del Castillo M, Lopez-Duarte M, Alonso L, Panesso M, Murillo-Sanjuan L, Fuentes C, Gomez G, Gonzalez-Vicent M, Verdu J and Diaz-de-Heredia C

Publicada: 1 dic 2024 Ahead of Print: 1 sep 2024
Resumen:


Filiaciones:
Uria-Oficialdegui ML:
 Pediatric Hematology and Oncology Division. Hospital Universitari Vall d ´Hebron, Barcelona, Spain

 Vall d´Hebron Research Institute (VHIR), Barcelona, Spain

 Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain

Quintero V:
 Pediatric Hematology and Oncology Department. Hospital Universitario La Paz, Madrid, Spain

Benitez-Carabante MI:
 Pediatric Hematology and Oncology Division. Hospital Universitari Vall d ´Hebron, Barcelona, Spain

 Vall d´Hebron Research Institute (VHIR), Barcelona, Spain

Bueno D:
 Pediatric Hematology and Oncology Department. Hospital Universitario La Paz, Madrid, Spain

Trabazo-del Castillo M:
 Pediatric Hematology and Oncology Department. Hospital Sant Joan de Déu, Barcelona, Spain

Lopez-Duarte M:
 Hematology and Hemotherapy Division. Hospital Universitario Marqués de Valdecilla, Santander, Spain

 Valdecilla Health Research Institute (IDIVAL), Santander, Spain

Alonso L:
 Pediatric Hematology and Oncology Division. Hospital Universitari Vall d ´Hebron, Barcelona, Spain

 Vall d´Hebron Research Institute (VHIR), Barcelona, Spain

Panesso M:
 Pediatric Hematology and Oncology Division. Hospital Universitari Vall d ´Hebron, Barcelona, Spain

 Vall d´Hebron Research Institute (VHIR), Barcelona, Spain

Murillo-Sanjuan L:
 Pediatric Hematology and Oncology Division. Hospital Universitari Vall d ´Hebron, Barcelona, Spain

 Vall d´Hebron Research Institute (VHIR), Barcelona, Spain

Fuentes C:
 Pediatric Hematology and Oncology Department. Hospital Universitario La Fe, Valencia, Spain

Gomez G:
 Pediatric Department. Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain

Gonzalez-Vicent M:
 Pediatric Hematology and Oncology Department. Hospital Universitario Niño Jesus, Madrid, Spain

Verdu J:
 Pediatric Hematology and Oncology Department. Hospital Clinic Universitario, Valencia, Spain

 Biomedical Research Institute, Valencia, Spain

Diaz-de-Heredia C:
 Pediatric Hematology and Oncology Division. Hospital Universitari Vall d ´Hebron, Barcelona, Spain

 Vall d´Hebron Research Institute (VHIR), Barcelona, Spain

 Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain
ISSN: 02683369





BONE MARROW TRANSPLANTATION
Editorial
SPRINGERNATURE, CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, Reino Unido
Tipo de documento: Letter
Volumen: 59 Número: 12
Páginas: 1773-1776
WOS Id: 001304635000001
ID de PubMed: 39227649

MÉTRICAS